Velarion Records
Free. Unsubscribe any time.

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Corbus Pharmaceuticals Holdings, Inc. filed 15 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 16 transactions and 114,585 shares. 15 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Corbus Pharmaceuticals Holdings, Inc. 16

Adoption dates in Corbus Pharmaceuticals Holdings, Inc. 6

Results prints in Corbus Pharmaceuticals Holdings, Inc. 0

Trades before a print in Corbus Pharmaceuticals Holdings, Inc. 0

Interval to Corbus Pharmaceuticals Holdings, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Corbus Pharmaceuticals Holdings, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on March 15, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.